세계의 GI 대변 검사 시장 보고서(2025년)
GI Stool Testing Global Market Report 2025
상품코드 : 1751009
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

GI 대변 검사 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 헬스케어 지출 증가, 패스트 푸드의 소비 증가, 맞춤형 의료에 대한 주목 증가 등에 기인한다고 생각됩니다. 예측 기간에 있어서의 주요 동향으로서는 진단 기술의 혁신, 분자진단학의 진보, 생물 제제의 진보, 맞춤형 의료의 대두, 전략적 제휴 등을 들 수 있습니다.

소화기 질환의 유병률 증가는 가까운 미래의 GI 대변 검사 시장 성장을 견인할 것으로 예측됩니다. 설탕의 다량 섭취, 저섬유식 등의 식생활의 혼란에 기인하고 있습니다. 이러한 요인은 장내 세균총을 방해해, 소화기계의 건강을 해치는 산역류, 과민성 장 증후군(IBS), 염증성 장 질환(IBD) 등의 증상의 일원이 됩니다. 장의 염증 마커, 소화 효소의 결핍을 검출하는 것으로, 감염증, 염증, 소화기계의 불균형을 특정하는 데 도움이 되기 때문에 이러한 질환의 진단에 필수적입니다. 예를 들어, 2024년 9월 미국 질병통제예방센터(CDC)는 2024년부터 2025년 사이에 NoroSTAT 참여 주에서 1,676건의 노로바이러스 발생을 보고했는데, 이는 전년 같은 기간에 기록한 729건보다 크게 증가한 수치입니다.

헬스케어 인프라의 확대는 GI 대변 검사 시장 성장을 더욱 촉진할 것으로 예상되고 있습니다. 중요한 물리적, 기술적, 조직적 시스템이 포함됩니다.이 인프라의 확장은 인구 증가와 노화에 의해 추진되고 있습니다. 개선을 보장하기 위해 더 많은 의료 시설이 필요하기 때문입니다. 그 결과, 소화기 질환이 보다 빠르고 정확하게 발견되어 시기 적절한 치료와 환자의 결과 개선이 가능하게 됩니다. 예를 들어, 2024년 11월 영국의 독립 자선단체인 The Health Foundation은 보건사회복지부의 지출이 2023/24년 2,276억 달러에서 2024/25년 2,386억 달러, 2025/26년 2,506억 달러로 증가하여 연평균 3.3%의 실질 성장률이 예상된다고 보고했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Gastrointestinal (GI) stool testing involves analyzing stool samples to evaluate gastrointestinal health, detect infections, digestive disorders, and inflammatory conditions. It aids in identifying microbial imbalances, digestive enzyme deficiencies, and markers of gut inflammation, making it a non-invasive diagnostic tool for early disease detection and personalized treatment planning.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of GI stool tests include immunoassay tests, molecular diagnostic tests, chromatography-based tests, microbiological culture tests, and enzyme-linked immunosorbent assay (ELISA). An immunoassay test is a diagnostic method that uses antibodies to identify specific antigens or proteins in stool samples. It can use both fecal and serum samples and requires various types of equipment, including automated analyzers, benchtop instruments, and portable devices. Immunoassay tests are used for diagnosing gastrointestinal disorders, screening for colorectal cancer, monitoring inflammatory bowel disease (IBD), detecting gastrointestinal infections, and evaluating digestive health. These tests are employed by hospitals, diagnostic centers and laboratories, academic institutions, research organizations, home care settings, and others.

The GI stool testing market research report is one of a series of new reports from The Business Research Company that provides GI stool testing market statistics, including GI stool testing industry global market size, regional shares, competitors with a GI stool testing market share, detailed GI stool testing market segments, market trends and opportunities, and any further data you may need to thrive in the GI stool testing industry. This GI stool testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The GI stool testing market size has grown strongly in recent years. It will grow from$1.32 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal diseases, increasing awareness of gut health, greater adoption of automated systems, growing disposable income, and the expanding geriatric population.

The GI stool testing market size is expected to see strong growth in the next few years. It will grow to$1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for efficient diagnostic instruments, the rising prevalence of colorectal cancer, higher healthcare expenditure, growing consumption of fast food, and an increasing focus on personalized medicine. Major trends in the forecast period include innovations in diagnostic technologies, advancements in molecular diagnostics, progress in biologics, the rise of personalized medicine, and strategic collaborations.

The growing prevalence of gastrointestinal disorders is anticipated to drive the growth of the GI stool testing market in the near future. Gastrointestinal disorders encompass conditions that affect the digestive system, including the stomach, intestines, and related organs, leading to symptoms such as nausea, diarrhea, constipation, and abdominal pain. The rise in such disorders is mainly attributed to poor dietary habits, including increased consumption of processed foods, high sugar intake, and low-fiber diets. These factors disrupt gut microbiota, impair digestive health, and contribute to conditions such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is essential for diagnosing these conditions as it helps identify infections, inflammation, or digestive imbalances by detecting pathogens (bacteria, viruses, parasites), markers of gut inflammation, and digestive enzyme deficiencies. This enables accurate diagnosis and targeted treatment. For example, in September 2024, the Centers for Disease Control and Prevention (CDC) reported 1,676 norovirus outbreaks in NoroSTAT-participating states between 2024 and 2025, marking a significant increase from the 729 outbreaks recorded during the same period the previous year. Thus, the rising prevalence of gastrointestinal disorders is fueling the growth of the GI stool testing market.

The expansion of healthcare infrastructure is expected to further propel the growth of the GI stool testing market. Healthcare infrastructure includes the physical, technological, and organizational systems needed to deliver medical services, such as hospitals, clinics, equipment, and digital health systems. The expansion of this infrastructure is driven by increasing populations and aging demographics, as longer life expectancies and a higher prevalence of diseases necessitate more medical facilities to ensure adequate healthcare access and improved patient outcomes. Enhanced healthcare infrastructures improve the accessibility and effectiveness of GI stool testing by providing advanced laboratory facilities, diagnostic technologies, and better-trained medical professionals. This leads to faster and more accurate detection of gastrointestinal disorders, enabling timely treatment and better patient outcomes. For instance, in November 2024, The Health Foundation, a UK-based independent charity, reported that the Department of Health and Social Care's spending is expected to increase from $227.6 billion in 2023/24 to $238.6 billion in 2024/25, and $250.6 billion in 2025/26, reflecting an average annual real-term growth of 3.3%. As such, the expansion of healthcare infrastructure supports the growth of the GI stool testing market.

Leading companies in the GI stool testing market are prioritizing advanced diagnostic technologies, such as comprehensive tests, to improve accuracy, speed, and early detection of diseases. Comprehensive diagnostic tests evaluate multiple health parameters at once, offering a thorough assessment of a condition. For example, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test designed to assist healthcare providers in diagnosing gastrointestinal disorders. This innovative test uses a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disturbances. With a 24-hour turnaround time, GI Detect allows for fast and informed clinical decision-making. In addition to broad pathogen detection, the test screens for Helicobacter pylori and its virulence factors-VacA, cagA, and babA-along with common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.

Major players in the GI stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor's Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, and ScheBo Biotech AG.

North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in GI stool testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the GI stool testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The GI stool testing market consists of revenues earned by entities by providing services such as microbiome analysis, pathogen detection, colorectal cancer screening, digestive health assessment, and inflammatory marker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The GI stool testing market also includes sales of stool test kits, reagent solutions, sample collection devices, diagnostic analyzers, and laboratory consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

GI Stool Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gi stool testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for gi stool testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gi stool testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. GI Stool Testing Market Characteristics

3. GI Stool Testing Market Trends And Strategies

4. GI Stool Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global GI Stool Testing Growth Analysis And Strategic Analysis Framework

6. GI Stool Testing Market Segmentation

7. GI Stool Testing Market Regional And Country Analysis

8. Asia-Pacific GI Stool Testing Market

9. China GI Stool Testing Market

10. India GI Stool Testing Market

11. Japan GI Stool Testing Market

12. Australia GI Stool Testing Market

13. Indonesia GI Stool Testing Market

14. South Korea GI Stool Testing Market

15. Western Europe GI Stool Testing Market

16. UK GI Stool Testing Market

17. Germany GI Stool Testing Market

18. France GI Stool Testing Market

19. Italy GI Stool Testing Market

20. Spain GI Stool Testing Market

21. Eastern Europe GI Stool Testing Market

22. Russia GI Stool Testing Market

23. North America GI Stool Testing Market

24. USA GI Stool Testing Market

25. Canada GI Stool Testing Market

26. South America GI Stool Testing Market

27. Brazil GI Stool Testing Market

28. Middle East GI Stool Testing Market

29. Africa GI Stool Testing Market

30. GI Stool Testing Market Competitive Landscape And Company Profiles

31. GI Stool Testing Market Other Major And Innovative Companies

32. Global GI Stool Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The GI Stool Testing Market

34. Recent Developments In The GI Stool Testing Market

35. GI Stool Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기